PMV Pharmaceuticals, Inc(NASDAQ:PMVP) 
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule, tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and r...
Website: http://www.pmvpharma.com
Full Time Employees: 39
CEO: David H. Mack
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 0.97
H 1.00
L 0.91
C 1.00
V 184,656
10EMA 1.00
20EMA 1.00
60EMA 1.00
120EMA 1.00
250EMA 1.00